Olaparib is an anti cancer medication used to treat prostate cancer, ovarian cancer, breast cancer, pancreatic cancer. It is sold under the brand name lynparza.
A PARP inhibitor is a cancer drug that blocks the activity of poly(ADP-ribose) polymerase (PARP), a protein crucial for DNA repair, leading to cell death in various cancers, including ovarian, breast, prostate, pancreatic, and fallopian tube cancers.
In 2020 there were 2.3 million women diagnosed with breast cancer and 6,85,000 deaths globally.
Breast cancer symptoms vary widely — from lumps to swelling to skin changes — and many breast cancers have no obvious symptoms at all.
